Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial

• Kristin Brekke,

  Affiliation Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway

  ⨯
• Andreas Lind,

  Affiliation Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway

  ⨯
• Carol Holm-Hansen,

  Affiliation Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Inger Lise Haugen,

  Affiliation Norwegian Institute of Public Health, Oslo, Norway

  ⨯
• Birger Sørensen,

  Affiliation Bionor Pharma, Oslo, Norway

  ⨯
• Maja Sommerfelt,

  Affiliation Bionor Pharma, Oslo, Norway

  ⨯
• Dag Kvale

  * E-mail: dag.kvale@medisin.uio.no

  Affiliations Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway, University of Oslo, Oslo, Norway

  ⨯